LN-229 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF4092
Target Cell Organism: Human
Target Cell Name: LN-229
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide LN-229-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LN-229
Target Cell Organism
Human
Target Cell Background
The LN-229 cell line was established in 1979 from cells taken from a patient with right frontal parieto-occipital glioblastoma [PubMed. 10416987].
Related Diseases
Glioblastoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
LN-229-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry